Olaratumab, the first new monoclonal antibody drug for advanced soft tissue sarcomaLI Fen-fen, ZHANG Dong-dong, LI Xiao-tian2241-2244
Clinical application and market status of drugs treating pulmonary arterial hypertensionMA Mei-ling, LIU Wen-dong, WANG Fang2245-2250
Analysis and discussion on standards of cinnabar and its preparations in Chinese Pharmacopoeia 2015 editionNIE Li-xing, DAI Zhong, YAO Ling-wen, MA Shuang-cheng2251-2260
Interpretation and thinking of announcement on evaluation and approval of package materials & pharmaceutical excipients associated with drug productsREN Lian-jie, MA Yu-nan, JIANG Yu, YU Huan, ZHANG Ling-chao2261-2265
Effects of small molecule vascular targeting anticancer drugs on non-target tissues and organsGUAN Xiao-yuan, HUA Lu, JIANG Li-xin2266-2270
Progress in research of the metabolic pathways and metabolites of major active constituents of Salvia miltiorrhizaLIN Rui, DUAN Jia-lin, MU Fei, BIAN Hai-xu, ZHAO Mei-na, WEN Ai-dong, XI Miao-miao2271-2277
Research progress of the detection of fatty acids by liquid chromatography-mass spectrometryZHAO Mei-na, DUAN Jia-lin, MU Fei, LIN Rui, XI Miao-miao2278-2284
Molecular mechanism of mitochondrial dynamics regulation and its relationship with β-amyloidYANG Han-yu, WANG Lu, ZANG Cai-xia, BAO Xiu-qi, ZHANG Dan2285-2290
Development of solubilization techniques for class Ⅱ drugs in biopharmaceutical classification systemHUO Tao-tao, TAO Chun, ZHANG Mei-jing, SONG Hong-tao2291-2299
Bioequivalence evaluation of two rhTNFR Ⅱ-Fc preparations from different manufacturing facilities in Chinese healthy volunteersDONG Li-hou, HAN Min, FAN Xiao-dong, XIE Xin-yao, WANG Bian-zhen, CHEN Fang, ZOU Jia, FU Jie, CHEN Fang-qing, OU Lun, SONG Hai-feng2300-2305